Suppr超能文献

利用新型 TP-PCR 试验对 DMPK 基因内的重复进行稳健且准确的检测和大小分析。

Robust and accurate detection and sizing of repeats within the DMPK gene using a novel TP-PCR test.

机构信息

Department of Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.

The BioFactory Pte Ltd, Singapore, Republic of Singapore.

出版信息

Sci Rep. 2019 Jun 4;9(1):8280. doi: 10.1038/s41598-019-44588-3.

Abstract

Myotonic dystrophy type 1 is a multisystem disorder caused by the expansion of a trinucleotide repeat in the DMPK gene. In this study we evaluated the performance of the FastDM1 DMPK sizing kit in myotonic dystrophy type 1 testing. This commercially available triplet repeat-primed PCR based kit was validated using reference and clinical samples. Based on testing with 19 reference samples, the assay yielded repeat sizes within three repeats from the consensus reference length, demonstrating an accuracy of 100%. Additionally, the assay generated consistent repeat size information with a concentration range of template-DNA, and upon repetition and reproduction (CV 0.36% to 0.41%). Clinical performance was established with 235 archived prenatal and postnatal clinical samples, yielding results of 100% sensitivity (95% CI, 97.29% to 100%) and 100% specificity (95% CI, 96.19% to 100%) in classifying the samples into the respective genotype groups of 5-35 (normal), 36-50 (non-pathogenic pre-expansion), 51-150 (unstable intermediate-sized pathogenic) or >150 (unstable pathogenic) CTG repeats, respectively. Furthermore, the assay identified interrupted repeat expansions in all samples known to have interruptions, and also identified interruptions in a subset of the clinical samples.

摘要

1 型肌强直性营养不良是一种多系统疾病,由 DMPK 基因三核苷酸重复扩展引起。本研究评估了 FastDM1 DMPK 基因大小分析试剂盒在 1 型肌强直性营养不良检测中的性能。该试剂盒是一种商业化的三重复引物 PCR 试剂盒,使用参考样本和临床样本进行了验证。基于对 19 个参考样本的测试,该检测方法产生的重复大小与共识参考长度相差三个重复,准确率达到 100%。此外,该检测方法在模板 DNA 的浓度范围内生成了一致的重复大小信息,并且具有可重复性和再现性(CV 为 0.36%至 0.41%)。通过对 235 个存档的产前和产后临床样本进行临床性能评估,该检测方法的敏感性为 100%(95%CI 为 97.29%至 100%),特异性为 100%(95%CI 为 96.19%至 100%),能够将样本准确地分为 5-35(正常)、36-50(非致病性前扩展)、51-150(不稳定中间致病性)或>150(不稳定致病性)CTG 重复的相应基因型组。此外,该检测方法能够识别所有已知存在中断的样本中的重复中断,并且还能够识别一部分临床样本中的中断。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e301/6547747/a34db5de0d6a/41598_2019_44588_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验